The San Diego Supercomputer Center at UC San Diego has announced the launch of ‘HPC Share’, a data sharing resource that will enable users of the Center’s high-performance computing resources to easily transfer, share, and discuss their data within their research teams and beyond.
Engineers have created light-based technology that can detect biological substances with a molecular mass more than two orders of magnitude smaller than previously possible. The work could lead to the development of ultra-sensitive devices for quickly detecting pathogens in blood.
UC San Diego bioengineers developed a control system that could make CAR T-cell therapy safer and more powerful when treating cancer. By programming CAR T cells to switch on when exposed to blue light, the researchers controlled the cells to destroy skin tumors in mice without harming healthy tissue
Six UC San Diego researchers have been named to receive prestigious 2020 Alfred P. Sloan Research Fellowships. Considered among the most promising researchers working today, the new UC San Diego Sloan fellows are part of a cohort of 126 early career scientists selected in the U.S. and Canada.
UC San Diego and IBM researchers reveal a new understanding of how our microbiomes change as we age, setting the stage for future research on the role microbes play in accelerating or decelerating the aging process and influencing age-related diseases.
Researchers at University of California San Diego School of Medicine, in collaboration with Mather Institute, developed a method to enhance resilience and reduce subjective stress in residents living in senior housing communities.
Researchers led by UC San Diego built a device that sorts and separates cancer cells from the same tumor based on how “sticky” they are. They found that less sticky cells migrate and invade other tissues more than their stickier counterparts, and have genes that make tumor recurrence more likely.
Micromotors that swim to infected sites in the body to lure, trap and destroy bacteria could offer a more efficient form of treatment against pathogens. UC San Diego nanoengineers have developed a “microtrap” that zips around in acid and serves as toxic bait for E. coli bacteria.
UC San Diego scientists have completed the first study in humans demonstrating that a common algae improves gastrointestinal issues related to irritable bowel syndrome. The green, single-celled organism called Chlamydomonas reinhardtii was found to help with diarrhea, gas and bloating.